For updates on COVID-19, please read.
Our world-class experts. Your child’s care team.
Explore Our Research
Exceptional science. Innovative cures.
Give to our mission.
Why support us?
When Eduardo was only 6 months old, a mass was discovered on his liver. Just when his mom was losing hope, he was referred to St. Jude.
Read This Patient's Story
Learn more about how you can help protect Memphis from COVID-19 by getting yourself and your loved ones vaccinated.
We have the world's best survival rates for some of the most aggressive cancers.
Join our anniversary year virtually or in-person! Register now for the marathon, half marathon, 10K, 5K or one of our multi-race challenges.
What happens when you give the world’s brightest minds the resources to do something remarkable? Cures.
St. Jude Inspire tells the stories that inspire trust, hope and faith in the mission that drives us: Finding cures. Saving children.
Read our new strategic plan and learn about our bold vision for the future.
Read This Article
Join our nationwide St. Jude Walk/Run during Childhood Cancer Awareness Month this September, and raise funds. With your support, we won’t stop until no child dies from cancer.
Read This Story
We share our research with the world, leading a global effort to understand, treat, and defeat pediatric cancer and other life-threatening diseases.
Join the adventure by downloading our activity sheet, watching a reading of the story and more.
St. Jude Children’s Research Hospital study highlights the power of comprehensive whole genome, whole exome and RNA sequencing to better understand and treat each patient’s cancer.
St. Jude scientists study how phase separation begins on a microsecond time scale, showing how the earliest events with individual molecules impact assembly speed.
A collaboration led by
St. Jude Children’s Research Hospital, Shanghai Children’s Medical Center and others revealed how thiopurines produce mutations that lead to multi-drug resistant leukemia and relapse.
St. Jude scientists looked at tumor samples from a Children’s Oncology Group clinical trial and assigned participants to molecular groups. The findings changed how the trial’s results were interpreted.
St. Jude Children’s Research Hospital scientists have shown that frailty contributes to neurocognitive decline in young adult survivors of childhood cancer.
William L. “Bill” Greene, PharmD, chief pharmaceutical officer, to receive the 2021 Shelby Rhinehart Public Service Lifetime Achievement Award.
More Science & Medicine